143
Participants
Start Date
July 31, 2012
Primary Completion Date
May 9, 2014
Study Completion Date
May 9, 2014
GEN-003 with Matrix M-2
IM administration of GEN-003 Vaccine with 50ug Matrix M-2 Adjuvant.
GEN-003
IM administration of GEN-003 Vaccine, antigens alone (without adjuvant).
Placebo
IM administration of 0.5 mL dose of Dulbecco's phosphate buffered saline.
Indiana University Infectious Disease Research, Indianapolis
Center for Clinical Studies - Houston, Houston
Center for Clinical Studies - Clear Lake/Webster, Webster
Westover Heights Clinic, Portland
UW Virology Research Clinic, Seattle
University of Alabama Vaccine Research Unit, Birmingham
Cincinnati Children's Hospital Medical Center, Cincinnati
Lead Sponsor
Genocea Biosciences, Inc.
INDUSTRY